India Intelligence Report
 

   India & China Work on Diabetic Drug

 

India and China, vying for the dubious distinction of being the diabetes capital of the world, are working together their vast herbal drug knowledge to identify medicine and herbs that can control diabetes.

Indian doctors have already identified herb Gurmara Booti (Gymnema Sylvetra) or sugar-destroyer. For centuries traditional medicine use the raisins found mostly in South India to control diabetes. Apparently, the Chinese side, led by Shanghai Medical College, has not identified an herb from China yet.

The whole project is facilitated by International Clinical Epidemiology Network (INCLEN). Clinical trial in India will be managed by Post Graduate Institute of Medical Education and Research in Chandigarh, Indian Council of Medical Research (ICMR) in New Delhi, and the Center for Evaluation of Traditional Ayurvedic Medicine.

INCLEN says it will submit a grant proposal to the ICMR which could cost USD 40,000 and expects to complete clinical trials in India in 18 months.

Home Page
Subscribe to receive this page daily by email
Unsubscribe from the mailing list